Seed amplification assays, those PCR-like reactions for toxic misfolded proteins, are starting to look pretty good. In the May Lancet Neurology, scientists led by Andrew Siderowf, University of ...
If your doctor suspects you have one of several diseases, they may want to perform an “enzyme-linked immunosorbent assay” test. This is more commonly known as an ELISA test, and it can help to confirm ...
Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Rebecca DuBois, associate professor of ...
Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening. Results from an early preclinical study suggest ...
Morning Overview on MSN
A genomic test spared two-thirds of high-risk breast-cancer patients from chemotherapy in a major trial
Women aged 40 and older with node-positive early breast cancer, a group traditionally routed straight to chemotherapy, may ...
The coronavirus disease 2019 (COVID-19) pandemic continues as many parts of the world grapple with skyrocketing cases. The global toll has reached 72.4 million cases, and 1.61 million have lost their ...
A $5 diagnostic test for COVID-19 won emergency authorization from the US Food and Drug Administration (FDA) on August 26 and could see widespread use by the end of this month. Abbott’s BinaxNOW COVID ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations Literature searches were conducted in MEDLINE (via PubMed) and EMBASE to identify studies published between January ...
Computational point-of-care sensors can significantly improve access to diagnostics by enabling rapid patient testing outside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results